Work with thought leaders and academic experts in genetics

Companies can benefit from working with someone whose expertise is in the field of genetics in several ways. Firstly, they can enhance their research and development efforts by leveraging the academic researcher's knowledge and insights. The researcher can provide valuable guidance in designing experiments, analyzing data, and interpreting results. Secondly, companies can tap into the researcher's expertise to develop innovative products and solutions. The researcher's deep understanding of genetics can help identify new opportunities and create cutting-edge technologies. Thirdly, collaborating with an academic researcher can enhance a company's credibility and reputation. By partnering with a recognized expert in the field, companies can demonstrate their commitment to scientific excellence and gain trust from customers and investors. Lastly, the researcher can also contribute to the company's thought leadership and industry influence. Their research findings and publications can position the company as a leader in the genetics field and attract attention from key stakeholders.

Researchers on NotedSource with backgrounds in genetics include Gwendolyn Thomas, Ph.D., CSCS, USAW-L1, Elvira Forte, Ping Luo, Regan Hamel, Luca Delfinis, Ajay Badhan, Tali Reiner Brodetzki, Aayudh Das, Ph.D., Boris Leibovitch, Michael W Harman, Daniel Milej, Ph.D., Sheed Itaman, Dr. Everson A Nunes, Ph.D., and Dr. David Siderovski, Ph.D..

Gwendolyn Thomas, Ph.D., CSCS, USAW-L1

Philadelphia, Pennsylvania, United States of America
17 Years Experience
Resistance Exercise Physiologist/Performance Enhancement/Optimizing RE Prescription
Education

University of Connecticut

Ph.D., Kinesiology (Exercise Endocrinology, Exercise Physiology, Resistance Exercise) / May, 2010

Storrs, Connecticut, United States of America

University of Connecticut

M.A., Strength and Conditioning / May, 2007

Storrs, Connecticut, United States of America
Experience

Penn State University

Assistant Research Professor / September, 2019 — August, 2023

Principal Investigator of the Exercise Prescription Lab. The lab (PI: Thomas) conducts interdisciplinary and translational research on chronic diseases, publishing in peer-reviewed journals. Transform population health outcomes through data, analytics, and actionable insights. Chair the regulatory review board, overseeing IRB Administration, running meetings, and approving research protocols. Expertise in institutional, FDA, and Federal regulatory work.

Penn State Integrative Physiology

Faculty Member / September, 2019 — Present

Faculty Member In Integrative Physiology

Syracuse University

Assistant Professor / August, 2016 — August, 2019

Independent Principal Investigator: Assumed responsibility for all research studies conducted in my lab, including but not limited to oversight and training of research assistants (25), training of research assistants (30), and generating independent, high quality, reproducible results. Responsible for the management and integrity of design, conduct and reporting of the research project and for managing, monitoring and ensuring the integrity of collaborative relationships. Curriculum Committee Chair:Led Curriculum Committee and Departmental Leadership to develop Master’s Degree in Strength and Conditioning through certifying agency, the National Strength and Conditioning Association (NSCA).

Most Relevant Research Expertise
Genetics
Other Research Expertise (30)
resistance exercise
obesity
breast cancer
chronic disease
inflammation
And 25 more
About
My work has focused on how we can use data to support decisions to individualize monitoring to optimize human performance.  My work has demonstrated that a one size fits all approach is not the way to optimize performance in any setting.  My monitoring approach is one that utilizes a network physiology paradigm, which focuses on nonlinear dynamic interactions. In my athlete monitoring I focus on leveraging EMA and wearables; biological sampling and resistance exercise and conditioning prescribed to elicit a specific biological response.    Additionally, as a practitioner it is important to understand the limitations of athlete monitoring, which is another area research and practice has focused.  This is an important skillset that is currently being utilized by the in a project entitled “Integrating mHealth and Physical Function to Develop a Predictors of Injury and Optimal Performance Model in Special Military Operators “with the Rangers in the 3/75 Ranger Battalion.  This approach is one that quantifies factors such as dosage variables of training and lifestyle factors (sleep, nutrition, life stress).  Using this data, we are working on individualizing acute training sessions to optimize readiness and performance enhancement.   During my time at Syracuse University, I was the professor of record to teach the NSCA CSCS preparation course and lead the strength and conditioning program.  We were developing a master’s in exercise science and I was in the process of working on certification with the NSCA.  We also worked closely with athletics to secure strength and conditioning assistantships to allow for student funding.  I am currently on several NSCA committees, which include the Education and Women’s Committee (next certification cycle).    I am particularly adept at all phases of the athletic performance enhancement and these experiences have given me expertise in evidence based program design, linear and non-linear periodization, exercise endocrinology, resistance exercise physiology and acute and chronic training readiness and non-training parameters
Most Relevant Publications (1+)

51 total publications

Multimodal prehabilitation in colorectal cancer patients to improve functional capacity and reduce postoperative complications: the first international randomized controlled trial for multimodal prehabilitation

BMC Cancer / Jan 22, 2019

van Rooijen, S., Carli, F., Dalton, S., Thomas, G., Bojesen, R., Le Guen, M., Barizien, N., Awasthi, R., Minnella, E., Beijer, S., Martínez-Palli, G., van Lieshout, R., Gögenur, I., Feo, C., Johansen, C., Scheede-Bergdahl, C., Roumen, R., Schep, G., & Slooter, G. (2019). Multimodal prehabilitation in colorectal cancer patients to improve functional capacity and reduce postoperative complications: the first international randomized controlled trial for multimodal prehabilitation. BMC Cancer, 19(1). https://doi.org/10.1186/s12885-018-5232-6

See Full Profile

Elvira Forte

New York, New York, United States of America
15 Years Experience
Scientific strategist • Senior Scientist • Senior Scientific Editor
Education

Sapienza University of Rome

PhD, Pasteurian Sciences / January, 2011

Rome

Sapienza University of Rome

Master, Medical, Molecular and Cellular Biotechnology / October, 2006

Rome

Sapienza University of Rome

Bachelor, Biotechnology / October, 2004

Rome
Experience

Springer Nature

Associate/Senior Editor / June, 2021 — February, 2024

Helped shape and launch a new journal, Nature Cardiovascular Research, which publishes exceptional advances in the fields of cardiac, vascular, and blood biology, covering fundamental, translational, clinical, and public health research. • Assessed the novelty and impact of manuscripts within all the topics covered by the journal and chaperoned the whole revision process until acceptance for over 40% of all the content published by the journal since its start, with optimal processing times and excellent feedback from the authors. • Interfaced with scientists around the World, provided scientific guidance on how to improve manuscripts, or recommended more appropriate journals to publish with. Commissioned Comments, Reviews, News and Views on current topics, and summarized novel scientific findings in meaningful snippets and Research Highlights. • Contributed to the training and supervision of 2 Associate Editors; covered the Chief Editor's functions when needed.

Research Fellow/Associate Research Scientist / January, 2017 — June, 2021

• Analyzed the dynamic cellular changes during the fibrotic repair post-myocardial infarction, using cutting-edge techniques such as single-cell RNAseq with 10xChromium. Learned how to perform myocardial infarction in mice and assess the cardiac function via echography; analyze scRNAseq data using the Seurat package on R studio. • Completed a project aimed to characterize similarities and differences among fibroblasts from different organs cultured in the same conditions. Through cytometric, transcriptomic analysis, functional assays, shRNA and CRISPR-Cas9-mediated in vitro gene knockdowns we showed that fibroblasts isolated from different organs retain the expression of key transcription factors reflecting their embryological origin. • Collaborated with other laboratories in the Institute to design new mice models that could possibly recapitulate the symptoms of COVID-19; to analyze the response of mice with diverse genetic backgrounds to stressors.

Post-doctoral fellow/ Co-joint lecturer / May, 2013 — November, 2016

Developed projects aimed at understanding the embryological origin and function of a population of putative progenitor cells, cardiac colony forming unit fibroblasts cCFU-F, identified 2 years before in the lab (PMID: 22136928). • Performed cell lineage tracing and designed in vitro and in vivo cellular assays to assess the functional and immunomodulatory properties of PDGFRa+ fibroblasts in homeostasis and post-myocardial infarction with or without treatment with the PDGF-AB ligands. The data, presented in 3 international conferences and included in a preprint manuscript, have supported the use of a short-term treatment with PDGF-AB in a preclinical model of acute myocardial infarction in pigs. • Co-supervised 2 Ph.D. students at University of New South Wales

Scientific Editor / March, 2024 — Present

Consultant freelancer position within a team of former journal editors and grants specialists • Helped scientists increase the impact of their science by providing advice, in-depth editing, and feedback on manuscripts.

Most Relevant Research Expertise
Genetics
Other Research Expertise (26)
fibrosis
inflammation
cardiomyopathies
Physiology
Cardiology and Cardiovascular Medicine
And 21 more
About
Motivated and growth-driven biomedical scientist with over 15 years of experience in the cardiovascular field. Strong background in cell and molecular biology, data analysis, and interpretation. Seeking #newopportunities to deliver value as a Senior Scientist, Associate Principal Scientist, Scientific Liaison, or Scientific Consultant within a company that combines new technologies such as single-cell omics and AI for drug discovery and personalized medicine. <br> Throughout my career, I've used various in vivo and in vitro models to investigate the molecular and cellular mechanisms of fibrosis and inflammation in the heart, and how these mechanisms are affected in mice with different genetic backgrounds. My experience includes project management and mentoring. I completed three projects involving international collaborations, supervised two junior researchers, and taught cellular and molecular techniques to at least six professionals. As one of the launching editors and senior editor at Nature Cardiovascular Research, I oversaw the quality of the content published in the journal and the editorial process. I collaborated with authors, reviewers, and editors to ensure the highest standards of scientific rigor, relevance, and innovation. I also contributed to the journal's vision, strategy, and outreach, promoting the latest advances and discoveries in the cardiovascular and hematology fields. This experience has sharpened my analytical and communication skills and broadened my understanding of the field, covering a wide range of studies, from basic research to clinical, epidemiological, and public health research. My mission is to advance the knowledge and practice of cardiovascular medicine and to bridge the gap between research and clinical applications. Keywords: cardiovascular, #fibrosis, inflammation, cardioimmunology, RNA, single-cell biology, #transcriptomics, imaging, animal models, small animal surgery, and scientific writing.
Most Relevant Publications (1+)

63 total publications

A Chemical Biology Approach to Myocardial Regeneration

Journal of Cardiovascular Translational Research / Mar 22, 2011

Willems, E., Lanier, M., Forte, E., Lo, F., Cashman, J., & Mercola, M. (2011). A Chemical Biology Approach to Myocardial Regeneration. Journal of Cardiovascular Translational Research, 4(3), 340–350. https://doi.org/10.1007/s12265-011-9270-6

See Full Profile

Ping Luo

Toronto, Ontario, Canada
8 Years Experience
Assistant Professor at Algoma University
Education

University of Saskatchewan

Ph.D., Biomedical Engineering / September, 2019

Saskatoon, Saskatchewan, Canada

Beijing Institute of Technology

M.Eng., Biomedical Engineering / June, 2015

Beijing

Hunan University

B.Eng., Computer Science / June, 2010

Changsha
Experience

Princess Margaret Cancer Centre

Postdoctoral Researcher / November, 2019 — Present

I work in Dr. Trevor Pugh's lab and design cancer diagnosis and treatment strategies by analyze cell-free DNA and single cell sequencing data

Princess Margaret Cancer Centre

Bioinformatics Specialist / September, 2023 — Present

I work in Dr. Tak Mak's lab and study tumor immunology using single cell and TCR sequencing data.

Most Relevant Research Expertise
Genetics
Other Research Expertise (21)
single-cell genomics
deep learning
complex network analysis
Genetics (clinical)
Molecular Medicine
And 16 more
About
8 years of science and engineering experience integrating multi-omics data to identify biomarkers for cancer studies. Seeking to apply data analytics expertise to develop new diagnosis and treatment strategies.
Most Relevant Publications (5+)

23 total publications

deepDriver: Predicting Cancer Driver Genes Based on Somatic Mutations Using Deep Convolutional Neural Networks

Frontiers in Genetics / Jan 29, 2019

Luo, P., Ding, Y., Lei, X., & Wu, F.-X. (2019). deepDriver: Predicting Cancer Driver Genes Based on Somatic Mutations Using Deep Convolutional Neural Networks. Frontiers in Genetics, 10. https://doi.org/10.3389/fgene.2019.00013

Disease Gene Prediction by Integrating PPI Networks, Clinical RNA-Seq Data and OMIM Data

IEEE/ACM Transactions on Computational Biology and Bioinformatics / Jan 01, 2019

Luo, P., Tian, L.-P., Ruan, J., & Wu, F.-X. (2019). Disease Gene Prediction by Integrating PPI Networks, Clinical RNA-Seq Data and OMIM Data. IEEE/ACM Transactions on Computational Biology and Bioinformatics, 16(1), 222–232. https://doi.org/10.1109/tcbb.2017.2770120

Identifying Disease-Gene Associations With Graph-Regularized Manifold Learning

Frontiers in Genetics / Apr 02, 2019

Luo, P., Xiao, Q., Wei, P.-J., Liao, B., & Wu, F.-X. (2019). Identifying Disease-Gene Associations With Graph-Regularized Manifold Learning. Frontiers in Genetics, 10. https://doi.org/10.3389/fgene.2019.00270

CReSCENT: CanceR Single Cell ExpressioN Toolkit

Nucleic Acids Research / Jun 01, 2020

Mohanraj, S., Díaz-Mejía, J. J., Pham, M. D., Elrick, H., Husić, M., Rashid, S., Luo, P., Bal, P., Lu, K., Patel, S., Mahalanabis, A., Naidas, A., Christensen, E., Croucher, D., Richards, L. M., Shooshtari, P., Brudno, M., Ramani, A. K., & Pugh, T. J. (2020). CReSCENT: CanceR Single Cell ExpressioN Toolkit. Nucleic Acids Research, 48(W1), W372–W379. https://doi.org/10.1093/nar/gkaa437

Evaluation of single-cell RNA-seq clustering algorithms on cancer tumor datasets

Computational and Structural Biotechnology Journal / Jan 01, 2022

Mahalanabis, A., Turinsky, A. L., Husić, M., Christensen, E., Luo, P., Naidas, A., Brudno, M., Pugh, T., Ramani, A. K., & Shooshtari, P. (2022). Evaluation of single-cell RNA-seq clustering algorithms on cancer tumor datasets. Computational and Structural Biotechnology Journal, 20, 6375–6387. https://doi.org/10.1016/j.csbj.2022.10.029

See Full Profile

Regan Hamel

Cambridge
6 Years Experience
Senior bioinformatics scientist, specializing in single cell omics in the context of cellular reprogramming and neuroinflammation
Education

University of Cambridge

PhD, Clinical Neurosciences / September, 2021

Cambridge

University of Cambridge

MPhil, Clinical Neurosciences / September, 2018

Cambridge

McGill University

Bachelor of Science, Neurosciences / June, 2017

Montreal
Experience

Mogrify Ltd

Bioinformatics scientist / August, 2021 — June, 2023

Senior Bioinformatics Scientist / July, 2023 — Present

Most Relevant Research Expertise
Genetics
Other Research Expertise (12)
single cell biology
transcriptomics
Cellular and Molecular Neuroscience
Cell Biology
Developmental Biology
And 7 more
About
Regan Hamel has an MPhil and PhD in Clinical Neurosciences from University of Cambridge. She also has a Bachelor of Science in Neurosciences from McGill University. Her PhD with Stefano Pluchino and John Marioni focused on single cell transcriptomics in the context of neuroinflammation. Since 2021 she has worked as a Bioinformatics scientist at Mogrify Ltd, applying a multitude of computational biology techniques (including single cell omics, bulk RNAseq, and predictive modelling) in the context of cell reprogramming
Most Relevant Publications (1+)

12 total publications

Combination of In Situ Lcn2 pRNA-RNAi Nanotherapeutics and iNSC Transplantation Ameliorates Experimental SCI in Mice

Molecular Therapy / Dec 01, 2020

Braga, A., Bandiera, S., Verheyen, J., Hamel, R., Rutigliani, C., Edenhofer, F., Smith, J. A., & Pluchino, S. (2020). Combination of In Situ Lcn2 pRNA-RNAi Nanotherapeutics and iNSC Transplantation Ameliorates Experimental SCI in Mice. Molecular Therapy, 28(12), 2677–2690. https://doi.org/10.1016/j.ymthe.2020.08.001

See Full Profile

Luca Delfinis

Toronto, Ontario, Canada
6 Years Experience
PhD candidate in physiology researching the mechanisms that drive muscle dysfunction in cancer
Education

Wilfrid Laurier University

BSc, Kinesiology & Physical Education / April, 2018

Waterloo, Ontario, Canada

York University

MSc, Molecular, Cellular and Integrative Physiology / August, 2020

Toronto, Ontario, Canada

York University

PhD, Molecular, Cellular and Integrative Physiology / August, 2024 (anticipated)

Toronto, Ontario, Canada
Experience

York University

Teaching Assistant / September, 2018 — Present

KINE 2049 (Research Methods in Kinesiology) and KINE 3012 (Human Physiology II)

Wilfrid Laurier University

Supplemental Instruction Senior Mentor / April, 2017 — April, 2018

Oversee teaching assistants with their teaching programs

Research Expertise (3)
Physiology
Physiology (medical)
Cell Biology
About
Luca Delfinis is a PhD candidate at York University where his research focuses on muscle dysfunction in cancer. Luca has been a part of several research collaborations both nationally and internationally throughout his PhD that has helped him gain unique perspectives in physiology, especially in the context of metabolism. He has also presented at several conferences where he has discussed data with leaders in cachexia, metabolism, exercise and more.

See Full Profile

Ajay Badhan

Lethbridge, Alberta, Canada
15 Years Experience
Research Biologist, Lethbridge Research Center, Canada
Education

Ph.D., Microbiology

Experience

Agriculture Agri-food Canada

Biologist / May, 2015 — Present

Most Relevant Research Expertise
Genetics
Other Research Expertise (26)
Animal nutrition
cell wall biosynthesis and its deconstruction
biofuels
Waste Management and Disposal
Renewable Energy, Sustainability and the Environment
And 21 more
About
I am a proficient researcher with valuable research and teaching experience acquired at distinguished institutes like Complex Carbohydrate Research Center, US, University of Alberta, Canada, and Lethbridge Research Center (AAFC), Canada. I have been working for past 15 years on multiple projects focused on the economical, environmental and social sustainability of agricultural production. Improvement in livestock performance, productivity, and health by unlocking the microbiome, development of clean technologies, improving agriculture environmental performance, and Increase agro-ecosystem resilience are prime objectives for my research.
Most Relevant Publications (4+)

29 total publications

Development of Cellulosic Secondary Walls in Flax Fibers Requires β-Galactosidase      

Plant Physiology / May 19, 2011

Roach, M. J., Mokshina, N. Y., Badhan, A., Snegireva, A. V., Hobson, N., Deyholos, M. K., & Gorshkova, T. A. (2011). Development of Cellulosic Secondary Walls in Flax Fibers Requires β-Galactosidase      . Plant Physiology, 156(3), 1351–1363. https://doi.org/10.1104/pp.111.172676

New recombinant fibrolytic enzymes for improved in vitro ruminal fiber degradability of barley straw1

Journal of Animal Science / Jul 20, 2018

Ribeiro, G. O., Badhan, A., Huang, J., Beauchemin, K. A., Yang, W., Wang, Y., Tsang, A., & McAllister, T. A. (2018). New recombinant fibrolytic enzymes for improved in vitro ruminal fiber degradability of barley straw1. Journal of Animal Science, 96(9), 3928–3942. https://doi.org/10.1093/jas/sky251

Mechanistic insights into the digestion of complex dietary fibre by the rumen microbiota using combinatorial high-resolution glycomics and transcriptomic analyses

Computational and Structural Biotechnology Journal / Jan 01, 2022

Badhan, A., Low, K. E., Jones, D. R., Xing, X., Milani, M. R. M., Polo, R. O., Klassen, L., Venketachalam, S., Hahn, M. G., Abbott, D. W., & McAllister, T. A. (2022). Mechanistic insights into the digestion of complex dietary fibre by the rumen microbiota using combinatorial high-resolution glycomics and transcriptomic analyses. Computational and Structural Biotechnology Journal, 20, 148–164. https://doi.org/10.1016/j.csbj.2021.12.009

PSX-15 Screening recombinant fibrolytic enzymes for improved ruminal fiber degradability of barley straw.

Journal of Animal Science / Dec 01, 2018

Ribeiro, G., Badhan, A., Huang, J., Beauchemin, K., Yang, W., Wang, Y., Tsang, A., & McAllister, T. (2018). PSX-15 Screening recombinant fibrolytic enzymes for improved ruminal fiber degradability of barley straw. Journal of Animal Science, 96(suppl_3), 413–414. https://doi.org/10.1093/jas/sky404.906

See Full Profile

Tali Reiner Brodetzki

Philadelphia , Pennsylvania, United States of America
5 Years Experience
Assistant Professor at La Salle University
Education

Tel Aviv University

Ph.D., Zoology / December, 2018

Tel Aviv
Experience

University of Pennsylvania

Postdoctoral Fellow / January, 2019 — August, 2021

Rutgers university

Postdoctoral Fellow / September, 2021 — August, 2022

La Salle University

Assistant Professor / August, 2022 — Present

Most Relevant Research Expertise
Genetics
Other Research Expertise (11)
Evolution
Social insects
Behavioral ecology
Population genetics
Epigenetics
And 6 more
About
Tali Reiner Brodetzki is a highly accomplished scientist with a strong background in zoology. She received her Ph.D. in Zoology from Tel Aviv University in 2018, where she focused on the study of animal behavior and evolutionary ecology. During her graduate studies, she published several papers in top scientific journals and received numerous awards for her research. After completing her Ph.D., Tali went on to work as a Postdoctoral Fellow at both the University of Pennsylvania and Rutgers University. During this time, she continued to conduct research on animal behavior and evolution, and also gained valuable experience in teaching and mentoring students. In 2020, Tali joined the faculty at La Salle University as an Assistant Professor in the Department of Biology. She is currently conducting research on the effects of human activities on animal behavior and adaptation, and is also teaching undergraduate and graduate courses in zoology, bioinformatics, genomics, and evolutionary biology. Tali's research has been widely recognized and she has received numerous grants and awards, including the prestigious European Molecular Biology Organisation's postdoctoral award. She is also a member of several professional organizations, including the Society for Integrative and Comparative Biology and the Animal Behavior Society. In addition to her academic and research accomplishments, Tali is also passionate about science outreach and communication. She regularly presents her research at conferences and seminars, and also participates in science fairs and other community events. She is dedicated to inspiring the next generation of scientists and promoting the importance of studying and protecting our natural world. Overall, Tali Reiner Brodetzki is a highly skilled and dedicated scientist who is making significant contributions to the field of zoology. Her education and experience have prepared her to continue making important discoveries and advancements in the study of animal behavior and evolution.
Most Relevant Publications (1+)

9 total publications

An integrative approach to untangling species delimitation in the Cataglyphis bicolor desert ant complex in Israel

Molecular Phylogenetics and Evolution / Oct 01, 2017

Eyer, P. A., Seltzer, R., Reiner-Brodetzki, T., & Hefetz, A. (2017). An integrative approach to untangling species delimitation in the Cataglyphis bicolor desert ant complex in Israel. Molecular Phylogenetics and Evolution, 115, 128–139. https://doi.org/10.1016/j.ympev.2017.07.024

See Full Profile

Aayudh Das, Ph.D.

Boston, Massachusetts, United States of America
10 Years Experience
Scientist at Garuda therapeutics, specialized in Genomics and Computational Biology
Education

University of Vermont

PhD, Plant Biology / April, 2022

Burlington, Vermont, United States of America

Texas A&M University

Master's in Biochemistry, Biochemistry & Biophysics / May, 2016

College Station, Texas, United States of America

University of Calcutta

Master's, Biotechnology

Kolkata
Experience

Garuda therapeutics

Scientist / July, 2023 — Present

The Pennsylvania State University - University Park Campus

Postdoctoral Researcher / June, 2022 — July, 2023

University of Vermont

Research Assistant / May, 2016 — May, 2022

Most Relevant Research Expertise
Genetics
Other Research Expertise (14)
Transcriptomics
Genomics
Proteomics
Computational Biology
Metabolomics
And 9 more
About
I am a dedicated Scientist-I at Garuda Therapeutics, where I specialize in computational biology and genomics within the R&D department. My work primarily revolves around developing and optimizing pipelines for variant calling using Strelka2 and GATK4 with Whole Genome Sequencing (WGS) to identify oncogenes in human induced pluripotent stem cells (iPSCs). This involves extensive work in the qualification and validation of these pipelines for regulatory filings, as well as leveraging databases such as ClinVar, COSMIC, and DepMap to craft targeted oncogenes panels for deep sequencing. I also apply Next-Generation Sequencing (NGS) for downstream sequencing to validate CRISPR knockouts, including the identification and validation of CRISPR off-targets using techniques like rhAMPseq and Induce-seq. Additionally, my expertise extends to single-cell sequencing analysis and understanding structural variants with Optical Genome Mapping (Bionano). Prior to joining Garuda Therapeutics, I completed a postdoctoral fellowship in computational biology at Pennsylvania State University, where I honed my skills in identifying climate-adaptive variants and conducted Genome-Wide Association Studies (GWAS) to uncover resistance genes against parasites and other stressors. My academic journey began at the University of Vermont, where I explored abiotic stress resistance genes using transcriptomics and developed a robust understanding of RNA-seq data analysis, from assembly to gene annotation. My work is driven by a passion for leveraging computational and genomics tools to address pressing challenges in biology and healthcare, combining my rigorous academic training with a practical, solution-oriented approach to research and development.
Most Relevant Publications (2+)

10 total publications

Investigation of the Cardiotonic Steroids, Marinobufagenin and Resibufogenin, in the Acute Respiratory Distress Syndrome

The FASEB Journal / Apr 01, 2016

Abbas, M. M. K., Chen, Q., Das, A., Oliver, J., Jiang, W., Moorthy, B., Patel, B., Morin, K., & Puschett, J. (2016). Investigation of the Cardiotonic Steroids, Marinobufagenin and Resibufogenin, in the Acute Respiratory Distress Syndrome. The FASEB Journal, 30(S1). Portico. https://doi.org/10.1096/fasebj.30.1_supplement.982.4

Testing the chilling‐ before drought‐tolerance hypothesis in Pooideae grasses

Molecular Ecology / Dec 07, 2022

Das, A., Dedon, N., Enders, D. J., Fjellheim, S., & Preston, J. C. (2022). Testing the chilling‐ before drought‐tolerance hypothesis in Pooideae grasses. Molecular Ecology, 32(4), 772–785. Portico. https://doi.org/10.1111/mec.16794

See Full Profile

Boris Leibovitch

New York, New York, United States of America
30 Years Experience
Experienced wet lab and in teaching Molecular Cell biologist, geneticist, cancer biologist in Academia
Education

Moscow Region State University

PhD, Molecular Biology / April, 1978

Moscow

Moscow Region State University

MS, Genetics / July, 1972

Moscow

Moscow Region State University

BS, Genetics / April, 1971

Moscow
Experience

NYU Langone Medical Center

Associate Research Scientist / June, 2021 — September, 2022

Wet lab research and teaching Molecular and Cell Biology in MD program

Icahn School of Medicine at Mount Sinai

Assistant Professor / July, 2004 — June, 2021

Wet lab research and teaching Molecular and Cell Biology in MD program

Washington University in St. Louis

Post-doctoral Research Associate / June, 1994 — June, 2004

Wet lab research and teaching Molecular and Cell Biology in MS program

Most Relevant Research Expertise
Genetics
Other Research Expertise (8)
Cancer Research
Cell Biology
Developmental Biology
Molecular Biology
Hematology
And 3 more
About
I am experienced molecular and cell biologist with deep genetics background who worked many years in USA and Russia on the bench and as teacher. Both types of work had demanded extremely broad knowledge and understanding of developments in the fields. Participation in grant writing, editorial/reviewer work for scientific journals and consulting colleagues on these subjects added a lot to my broad experience as the scientist.
Most Relevant Publications (9+)

22 total publications

Analyzing Heterochromatin Formation Using Chromosome 4 of Drosophila melanogaster

Cold Spring Harbor Symposia on Quantitative Biology / Jan 01, 2004

HAYNES, K. A., LEIBOVITCH, B. A., RANGWALA, S. H., CRAIG, C., & ELGIN, S. C. R. (2004). Analyzing Heterochromatin Formation Using Chromosome 4 of Drosophila melanogaster. Cold Spring Harbor Symposia on Quantitative Biology, 69(0), 267–272. https://doi.org/10.1101/sqb.2004.69.267

A heat-shock-activated cDNA encoding GAGA factor rescues some lethal mutations in the Drosophila melanogaster Trithorax-like gene

Genetical Research / Aug 01, 2001

GRANOK, H., LEIBOVITCH, B. A., & ELGIN, S. C. R. (2001). A heat-shock-activated cDNA encoding GAGA factor rescues some lethal mutations in the Drosophila melanogaster Trithorax-like gene. Genetical Research, 78(1), 13–21. https://doi.org/10.1017/s0016672301005122

Chromatin organization and transcriptional control of gene expression in Drosophila

Gene / Aug 01, 2000

Farkas, G., Leibovitch, B. A., & Elgin, S. C. R. (2000). Chromatin organization and transcriptional control of gene expression in Drosophila. Gene, 253(2), 117–136. https://doi.org/10.1016/s0378-1119(00)00240-7

Mutations That Affect Ion Channels Change the Sensitivity ofDrosophila Melanogasterto Volatile Anesthetics

Journal of Neurogenetics / Jan 01, 1995

Leibovitch, B. A., Campbell, D. B., Krishnan, K. S., & Nash, H. A. (1995). Mutations That Affect Ion Channels Change the Sensitivity ofDrosophila Melanogasterto Volatile Anesthetics. Journal of Neurogenetics, 10(1), 1–13. https://doi.org/10.3109/01677069509083455

Telomeres and P-element of Drosophila melanogaster contain sequences that replicate autonomously in Saccharomyces cerevisiae

Molecular and General Genetics MGG / Nov 01, 1984

Danilevskaya, O. N., Kurenova, E. V., Leibovitch, B. A., Shevelev, A. Ya., Bass, I. A., & Khesin, R. B. (1984). Telomeres and P-element of Drosophila melanogaster contain sequences that replicate autonomously in Saccharomyces cerevisiae. Molecular and General Genetics MGG, 197(2), 342–344. https://doi.org/10.1007/bf00330983

Increase in the number of histone genes in case of their deficiency in Drosophila melanogaster

Molecular and General Genetics MGG / Jul 01, 1980

Chernyshev, A. I., Bashkirov, V. N., Leibovitch, B. A., & Khesin, R. B. (1980). Increase in the number of histone genes in case of their deficiency in Drosophila melanogaster. Molecular and General Genetics MGG, 178(3), 663–668. https://doi.org/10.1007/bf00337876

Influence of deficiency of the histone gene-containing 38B-40 region on X-chromosome template activity and the White gene position effect variegation in Drosophila melanogaster

Molecular and General Genetics MGG / Jan 01, 1978

Khesin, R. B., & Leibovitch, B. A. (1978). Influence of deficiency of the histone gene-containing 38B-40 region on X-chromosome template activity and the White gene position effect variegation in Drosophila melanogaster. Molecular and General Genetics MGG, 162(3), 323–328. https://doi.org/10.1007/bf00268858

Comparison of in vivo and in vitro RNA synthesis on polytene chromosomes of Drosophila

Chromosoma / Jan 01, 1976

Leibovitch, B. A., Belyaeva, E. S., Zhimulev, I. F., & Khesin, R. B. (1976). Comparison of in vivo and in vitro RNA synthesis on polytene chromosomes of Drosophila. Chromosoma, 54(4), 349–362. https://doi.org/10.1007/bf00292815

Synthesis of RNA by Escherichia coli RNA polymerase on the chromosomes of Drosophila melanogaster

Chromosoma / Jan 01, 1974

Khesin, R. B., & Leibovitch, B. A. (1974). Synthesis of RNA by Escherichia coli RNA polymerase on the chromosomes of Drosophila melanogaster. Chromosoma, 46(2), 161–172. https://doi.org/10.1007/bf00332514

See Full Profile

Michael W Harman

East Greenwich, RI, Rhode Island, United States of America
7 Years Experience
Distinguished Subject Matter Expert & Leader in Medical Technologies.
Education

University of Connecticut

BS, Biomedical Engineering, Biofluid Mechanics Track / May, 2008

Storrs, Connecticut, United States of America

University of Connecticut

MS, Biomedical Engineering, Biomechanics Concentration / December, 2009

Storrs, Connecticut, United States of America

University of Arizona

Ph.D, Biochemistry, Molecular and Cellular Biology / December, 2015

Tucson, Arizona, United States of America
Experience

Brown University

Postdoctoral Research Fellow / May, 2016 — August, 2018

Critical lead asset driving preclinical collaborative cell biomechanics study managing 30 personnel between immunology, pathobiology, and experimental soft matter mechanics laboratories.

Rhode Island Hospital

Postdoctoral Research Fellow / May, 2016 — August, 2018

Critical lead asset driving preclinical collaborative cell biomechanics study managing 30 personnel between immunology, pathobiology, and experimental soft matter mechanics laboratories.

Ximedica

Research & Development Engineer / September, 2018 — October, 2019

Provided technical subject matter expertise to enhance the clinical performance of novel medical products being designed.

Research & Development Engineering Manager / October, 2019 — July, 2020

Grew a team of Research & Development Engineers out of our traditional designer, mechanical, and electrical engineering departments to form a novel team within the organization and supported each of their individual professional development needs.

Most Relevant Research Expertise
Genetics
Other Research Expertise (13)
Bacteria & Cell Bio-Physics
Biomechanics
Infectious Diseases
Immunology
Microbiology
And 8 more
About
Highly skilled, energetic, and motivated professional empowered by over a decade of cross-disciplinary engineering and scientific applications experience. Presenting elegant solutions to prevalent biomedical challenges. Motivated by driving deliverable outcomes from complex research studies through effective leadership, active consulting work, and innovative problem-solving techniques. Seeking to make an immediate impact in a fast-paced biotechnology environment capitalizing on my advanced comprehension, continued professional growth, strategic product development expertise, and active network of personal connections across all areas of science, engineering, medicine, manufacturing and healthcare.
Most Relevant Publications (2+)

15 total publications

The induction of endoreduplication and polyploidy by elevated expression of 14-3-3γ

Genes &amp; Cancer / Dec 24, 2017

Gomes, C. J., Centuori, S. M., Harman, M. W., Putnam, C. W., Wolgemuth, C. W., & Martinez, J. D. (2017). The induction of endoreduplication and polyploidy by elevated expression of 14-3-3γ. Genes &amp; Cancer, 8(11–12), 771–783. https://doi.org/10.18632/genesandcancer.161

Vinculin in Neutrophil Adhesion, Motility and Trafficking

The FASEB Journal / Apr 01, 2018

Wilson, Z., Harman, M., Hazlett, L., Odzer, J., Witt, H., Franck, C., Reichner, J., & Lefort, C. (2018). Vinculin in Neutrophil Adhesion, Motility and Trafficking. The FASEB Journal, 32(S1). Portico. https://doi.org/10.1096/fasebj.2018.32.1_supplement.280.11

See Full Profile

Daniel Milej, Ph.D.

London, Ontario, Canada
15 Years Experience
Ph.D. in biomedical engineering
Education

Western University

Post-doctorate fellowship, Department of Medical Biophysics / June, 2019

London

Polish Academy of Science

PhD, Nalecz Institute of Biocybernetics and Biomedical Engineering / June, 2014

Warsaw

Military Univeristy of Technology

MSc, Department of Electronics / June, 2008

Warsaw
Experience

Lawson Research Institute

Research Associate / July, 2019 — July, 2025

Scientist / August, 2024 — Present

Western University

Postdoctoral fellow / September, 2014 — June, 2019

Assistant Professor / September, 2024 — Present

Polish Academy of Science

Researcher/PhD Student / June, 2008 — September, 2014

Most Relevant Research Expertise
Genetics
Other Research Expertise (31)
Biomedical Optics
NIRS
fNIRS
Diffuse Correlation Spectroscopy
CBF
And 26 more
About
Dr. Daniel Milej is a multidisciplinary researcher with experience in medical biophysics, electronics, biocybernetics, biomedical optics and engineering. He is highly knowledgeable and experienced in a range of research techniques. He is a Scientist at the Lawson Research Institute, leading the transition of multimodal optical imaging systems from a research setting to clinical use in an ICU and OR environment, working closely with teams of nurses, surgeons, doctors and respiratory therapists. Previously, he was a Postdoctoral Fellow and Research Associate working on developing noninvasive modalities for brain activity monitoring in the Department of Medical Biophysics at Western University. Before that, Dr. Milej worked as a Researcher at the Nalecz Institute of Biocybernetics and Biomedical Engineering. He obtained his Ph.D. in 2014 from the Polish Academy of Science, specializing in Biocybernetics and Biomedical Engineering. He received his MSc in Electronics/Optoelectronics from the Military University of Technology, Warsaw, Poland, in 2008.
Most Relevant Publications (1+)

91 total publications

Assessment by Multi‐Distance Hyperspectral NIRS of Changes in the Oxidation State of Cytochrome C Oxidase (oxCCO) to Carotid Artery Compressions

The FASEB Journal / May 01, 2022

Shoemaker, L., Suwalski, M., Milej, D., Shoemaker, J. K., Chui, J., & St. Lawrence, K. (2022). Assessment by Multi‐Distance Hyperspectral NIRS of Changes in the Oxidation State of Cytochrome C Oxidase (oxCCO) to Carotid Artery Compressions. The FASEB Journal, 36(S1). Portico. https://doi.org/10.1096/fasebj.2022.36.s1.r3459

See Full Profile

Sheed Itaman

New York, New York, United States of America
8 Years Experience
Neurobiologist | Biopharma Consultant | Let's Connect!
Education

Stony Brook University

Ph.D., Neurobiology and behavior / December, 2022

Stony Brook, New York, United States of America

Delaware State University

MS, Molecular and Cellular Neuroscience / May, 2016

Dover, Delaware, United States of America

University of Houston

BS, Biochemical and Biophysical Sciences / May, 2012

Houston, Texas, United States of America
Experience

The National Institute for Health (NIH)/Center for Biotechnology

Consultant / August, 2022 — Present

• Develop due-diligence reports on emerging company clients • Market and competitive analysis • Wrote brief regulatory summaries • Performed investor/strategic partner research • Wrote reports that focus on the end-users of the products to develop growth strategy insights

Research Expertise (0)
About
1. Eight years of wet laboratory and lab management experience 2. Excellent organizational, analytical and technical skills to execute effectively on complex projects and meet tight timelines 3. Outstanding interpersonal and communication skills; multiple awards for presentations and writing # TECHNICAL SKILLS 1. **Animal Handling:** Mouse handling, tissue harvest, IV/IP/IM/SC injections 2. **Cell Biology:** Cell culture, Cell assays, Cell fractionation 3. **Microscopy/Imaging:** Confocal microscopy, Cell imaging and analysis 4. **Tissue Culture:** Primary cell isolation and culture 5. **Biochemistry:** Western Blotting, BCA protein assay, Bradford assay, IHC, IP 6. **Molecular biology:** PCR, transfection, transduction, mini prep, DNA/RNA isolation

See Full Profile

Dr. Everson A Nunes, Ph.D.

Hamilton, Ontario, Canada
19 Years Experience
Post-Doctoral Fellow at McMaster University | former Associate Professor - Physiological Sciences
Education

Universidade Federal do Paraná - Campus Centro Politécnico

PhD, Physiological Sciences / December, 2009

Curitiba

Universidade Federal do Paraná - Campus Centro Politécnico

BSc - Human Nutrition / December, 2007

Curitiba

Universidade Federal do Paraná - Campus Centro Politécnico

MSc, Physiological Sciences / March, 2005

Curitiba
Experience

McMaster University

Post Doctoral Fellow / September, 2019 — Present

Post-Doctoral Research Fellow / September, 2015 — August, 2016

Universidade Federal de Santa Catarina

Associate professor / October, 2013 — April, 2022

Assistant Professor / October, 2010 — September, 2013

Universidade Federal do Paraná

Post-Doctoral Fellow / December, 2009 — September, 2010

Most Relevant Research Expertise
Genetics
Other Research Expertise (39)
skeletal muscle
nutrition
physical activity
obesity
cancer
And 34 more
About
Dr. Everson A Nunes is a highly accomplished researcher and educator in the field of physiological sciences. He received his Ph.D. in Cellular and Molecular Biology with a focus on Physiological Sciences from Universidade Federal do Paraná in 2009, after completing a BSc in Human Nutrition and an MSc in Physiological Sciences. He also holds a specialization in Exercise Physiology and a BSc in Biological Sciences from Universidade Federal do Paraná. Dr. Nunes has a strong background in research, having completed two post-doctoral fellowships at McMaster University and Universidade Federal do Paraná. He has also held positions as an associate professor and assistant professor at Universidade Federal de Santa Catarina. He has published numerous articles in peer-reviewed journals, and his research focuses on the effects of exercise and nutrition on physiological processes in the human body. In addition to his research, Dr. Nunes is also a dedicated educator. He has taught at various universities in Brazil, including Universidade Federal de Santa Catarina, Universidade Gama Filho, Faculdades Integradas Espírita, Pontificia Universidade Católica do Paraná, and Faculdade do Litoral Sul. He is known for his dynamic teaching style and his ability to engage students in complex physiological concepts. Dr. Nunes is a member of several professional organizations, including the American Society for Nutrition, the Canadian Society of Exercise Physiology, the Canadian Nutrition Society and the Brazilian Society of Physiology. He is also a regular speaker at national and international conferences, sharing his expertise and research findings with colleagues and students. Overall, Dr. Nunes is a highly qualified and experienced professional in physiological sciences, metabolism, cancer and nutrition. His dedication to research and education makes him a valuable asset to any institution.
Most Relevant Publications (1+)

97 total publications

Relationship between Acute Phase Proteins and Serum Fatty Acid Composition in Morbidly Obese Patients

Disease Markers / Jan 01, 2013

Fernandes, R., Beserra, B. T. S., Cunha, R. S. G., Hillesheim, E., Camargo, C. de Q., Pequito, D. C. T., de Castro, I. C., Fernandes, L. C., Nunes, E. A., & Trindade, E. B. S. de M. (2013). Relationship between Acute Phase Proteins and Serum Fatty Acid Composition in Morbidly Obese Patients. Disease Markers, 35, 105–112. https://doi.org/10.1155/2013/913715

See Full Profile

Dr. David Siderovski, Ph.D.

Fort Worth
25 Years Experience
Professor of Computational Pharmacology; Chair of HSC SBS Dept. of Pharmacology & Neuroscience
Education

University of Toronto

Ph.D., Medical Biophysics / November, 1997

Toronto, Ontario, Canada
Experience

University of North Carolina at Chapel Hill

Professor / January, 1999 — June, 2012

West Virginia University School of Medicine

E.J. Van Liere Endowed Medicine Professor and Chairman / July, 2012 — February, 2020

Chair of the Dept. of Physiology and Pharmacology

University of North Texas Health Science Center

Professor & Chair / March, 2020 — Present

Most Relevant Research Expertise
Genetics
Other Research Expertise (25)
Regulator of G protein Signaling (RGS) proteins
Pharmacology
Molecular Biology
Cellular and Molecular Neuroscience
Molecular Medicine
And 20 more
About
Dr. David Siderovski is a renowned scientist and academic, with a career spanning over two decades. He received his Ph.D. in Medical Biophysics from the University of Toronto in 1997, where he specialized in signal transduction and cellular signaling pathways. After completing his doctorate, Dr. Siderovski held various faculty positions at prestigious universities, including the University of North Carolina at Chapel Hill, West Virginia University School of Medicine, and the University of North Texas Health Science Center. At these institutions, Dr. Siderovski has made significant contributions to the field of pharmacology through his research on G protein-coupled receptors (GPCRs) and RGS proteins, which are key regulators of GPCR cellular signaling. His work has helped to advance the understanding of RGS proteins and their roles in various diseases, including cancer, cardiovascular disorders, and neurological disorders. In addition to his research, Dr. Siderovski is also a dedicated educator and mentor. He has taught and mentored numerous undergraduate, graduate, and medical students, and has served as a mentor for postdoctoral fellows and junior faculty members. He is known for his passion and enthusiasm for science and his ability to inspire and guide the next generation of scientists. Dr. Siderovski has received numerous awards and honors for his contributions to the scientific community. He was the recipient of the Abel Award in 2004 from the American Society of Pharmacology & Experimental Therapeutics for his pioneering discoveries of the RGS proteins and the GoLoco motif. He has also served on editorial boards of several scientific journals (including a decade at *J.Biol.Chem.*) and has been a member of various scientific committees, NIH study section panels, and pharma/biotech advisory boards, including for Inspire, Wyeth, and BellBrook Labs. Overall, Dr. David Siderovski is a highly accomplished and respected scientist and educator, whose research has had a significant impact on the field of pharmacology. His dedication and passion for science continue to inspire and influence the next generation of researchers in this field.
Most Relevant Publications (8+)

94 total publications

5′-Capping enzymes are targeted to pre-mRNA by binding to the phosphorylated carboxy-terminal domain of RNA polymerase II

Genes &amp; Development / Dec 15, 1997

McCracken, S., Fong, N., Rosonina, E., Yankulov, K., Brothers, G., Siderovski, D., Hessel, A., Foster, S., Program, A. E., Shuman, S., & Bentley, D. L. (1997). 5′-Capping enzymes are targeted to pre-mRNA by binding to the phosphorylated carboxy-terminal domain of RNA polymerase II. Genes &amp; Development, 11(24), 3306–3318. https://doi.org/10.1101/gad.11.24.3306

Structural basis for the selective activation of Rho GTPases by Dbl exchange factors

Nature Structural Biology / May 13, 2002

Snyder, J. T., Worthylake, D. K., Rossman, K. L., Betts, L., Pruitt, W. M., Siderovski, D. P., Der, C. J., & Sondek, J. (2002). Structural basis for the selective activation of Rho GTPases by Dbl exchange factors. Nature Structural Biology, 9(6), 468–475. https://doi.org/10.1038/nsb796

Molecular cloning ofLSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE)

Nucleic Acids Research / Jan 01, 1995

Matsuyama, T., Grossman, A., Mittrücker, H.-W., Siderovski, D. P., Kiefer, F., Kawakami, T., Richardson, C. D., Taniguchi, T., Yoshinaga, S. K., & Mak, T. W. (1995). Molecular cloning ofLSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Research, 23(12), 2127–2136. https://doi.org/10.1093/nar/23.12.2127

A Human Gene Encoding a Putative Basic Helix–Loop–Helix Phosphoprotein Whose mRNA Increases Rapidly in Cycloheximide-Treated Blood Mononuclear Cells

DNA and Cell Biology / Feb 01, 1994

SIDEROVSKI, D. P., HEXIMER, S. P., & FORSDYKE, D. R. (1994). A Human Gene Encoding a Putative Basic Helix–Loop–Helix Phosphoprotein Whose mRNA Increases Rapidly in Cycloheximide-Treated Blood Mononuclear Cells. DNA and Cell Biology, 13(2), 125–147. https://doi.org/10.1089/dna.1994.13.125

Cloning of Human Lymphocyte-Specific Interferon Regulatory Factor (hLSIRF/hIRF4) and Mapping of the Gene to 6p23–p25

Genomics / Oct 01, 1996

Grossman, A., Mittrücker, H.-W., Nicholl, J., Suzuki, A., Chung, S., Antonio, L., Suggs, S., Sutherland, G. R., Siderovski, D. P., & Mak, T. W. (1996). Cloning of Human Lymphocyte-Specific Interferon Regulatory Factor (hLSIRF/hIRF4) and Mapping of the Gene to 6p23–p25. Genomics, 37(2), 229–233. https://doi.org/10.1006/geno.1996.0547

A Set of Human Putative Lymphocyte G0/G1Switch Genes Includes Genes Homologous to Rodent Cytokine and Zinc Finger Protein-Encoding Genes

DNA and Cell Biology / Oct 01, 1990

SIDEROVSKI, D. P., BLUM, S., FORSDYKE, R. E., & FORSDYKE, D. R. (1990). A Set of Human Putative Lymphocyte G0/G1Switch Genes Includes Genes Homologous to Rodent Cytokine and Zinc Finger Protein-Encoding Genes. DNA and Cell Biology, 9(8), 579–587. https://doi.org/10.1089/dna.1990.9.579

Cloning of a retinally abundant regulator of G-protein signaling (RGS-r/RGS16): genomic structure and chromosomal localization of the human gene

Gene / Jan 01, 1998

Snow, B. E., Antonio, L., Suggs, S., & Siderovski, D. P. (1998). Cloning of a retinally abundant regulator of G-protein signaling (RGS-r/RGS16): genomic structure and chromosomal localization of the human gene. Gene, 206(2), 247–253. https://doi.org/10.1016/s0378-1119(97)00593-3

A P-loop Mutation in Gα Subunits Prevents Transition to the Active State: Implications for G-protein Signaling in Fungal Pathogenesis

PLoS Pathogens / Feb 23, 2012

Bosch, D. E., Willard, F. S., Ramanujam, R., Kimple, A. J., Willard, M. D., Naqvi, N. I., & Siderovski, D. P. (2012). A P-loop Mutation in Gα Subunits Prevents Transition to the Active State: Implications for G-protein Signaling in Fungal Pathogenesis. PLoS Pathogens, 8(2), e1002553. https://doi.org/10.1371/journal.ppat.1002553

See Full Profile

Example genetics projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on genetics?

Genetic Testing for Personalized Medicine

A pharmaceutical company can collaborate with a genetics researcher to develop genetic tests that predict individual responses to medications. This can help optimize treatment plans and improve patient outcomes.

Crop Improvement through Genetic Engineering

An agricultural company can partner with a genetics expert to enhance crop traits through genetic engineering. This can lead to improved yields, disease resistance, and nutritional value.

Genomic Data Analysis for Precision Agriculture

A technology company can work with a genetics researcher to analyze genomic data and provide insights for precision agriculture. This can optimize resource allocation, improve crop management, and reduce environmental impact.

Genetic Counseling Services

A healthcare company can collaborate with a genetics specialist to offer genetic counseling services. This can help individuals understand their genetic risks, make informed decisions, and manage their health proactively.

Drug Discovery and Target Identification

A biotechnology company can partner with a genetics researcher to identify potential drug targets based on genetic insights. This can accelerate the discovery and development of novel therapeutics.